Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
September 24, 2025
Obesity Weekly News – September 23rd 2025
September 24, 2025
Immunology Weekly News – September 24th 2025
September 24, 2025
Lucid Diligence Brief: Salt AI $10M raise
September 23, 2025
Artificial Intelligence and Digital Health News – September 23rd 2025
September 23, 2025
Latest Artificial Intelligence and Digital Health News – Sept 9th to Sept 23rd 2025
September 23, 2025
Endocrinology Weekly Update – September 23rd 2025
September 22, 2025
Hematology Weekly News – September 22nd 2025
September 22, 2025
Oncology Weekly News – September 22nd 2025
September 19, 2025
Vaccines Weekly Update – September 19th 2025
September 19, 2025
Public Health Weekly News – September 19th 2025
September 19, 2025
Respiratory Today—September 19, 2025
September 18, 2025